Острый кардиоренальный синдром у больного с декомпенсацией хронической сердечной недостаточности


Ж.Д. Кобалава, С.В. Виллевальде, А.С. Клименко, М.А. Ефремовцева, А.С. Мильто

Кафедра пропедевтики внутренних болезней ФГБОУ ВПО РУДН, Москва
Представлен случай развития кардиоренального синдрома 1-го типа у пациента с острой декомпенсацией хронической сердечной недостаточности и нарушением функции почек в анамнезе.

Литература



  1. Ronco C., Haapio M., House A.A. et al. Cardiorenal syndrome. JACC 2008; 52: 1527-1539.

  2. Bock J.S., Gottlieb S.S. Cardiorenal Syndrome: New Perspectives. Circulation 2010; 121:2592-2600.

  3. Latchamsetty R., Fang J., Kline-Rogers E. et al. Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome. Am. J. Cardiol. 2007; 99(7): 939-42.

  4. Jose P., Skali H., Anavekar N. et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J. Am. Soc. Nephrol. 2006; 17(10): 2886-2891.

  5. KDIGO Clinical practice guideline for acute kidney injury. Kidney Int. 2012; 2(1): 1-141.

  6. Cowie M. R., Komajda M., Murray-Thomas T. et al. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur. Heart J. 2006; 27(10): 1216-1222.

  7. Krumholz H. M., Chen YA. T., Vaccarino V. et al. Correlates and impact on outcomes of worsening renal function in patients > 65 years of age with heart failure. Am. J. Cardiol. 2000; 85(9): 1110-1113.

  8. Adams K., Fonarow G., Emerman C. et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE). Am. Heart J. 2005;149: 209-216.

  9. Fonarow G., Stough W., Abraham W. et al. Characteristics, treatments, and outcomes ofpatients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HFregistry. J. Am. Coll. Cardiol. 2007;50: 768-777.

  10. Liu P.P. Cardiorenal syndrome in heart failure: a cardiologist’s perspective. Can. J. Cardiol. 2008; 24 (Suppl.): 25B-29B.

  11. Forman D.E., Butler J., Wang Y. et al. Incidence, predictors at admission, and impact of worsening of renalfunction among patients hospitalized with heart failure. J. Am. Coll. Cardiol. 2004; 43(1):61-67.

  12. Valle R., Aspormonte N, Milani L. et al. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev 2011; 16 (6): 519-29.

  13. Parrinello G., Paterna S. et al. The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J. Card. Fail 2008; 14: 676-686.

  14. Heywood J.T. The cardiorenal syndrome: lessons from the ADHERE database and treatment options. Heart Fail Rev 2004; 9: 195-201.

  15. Ronco C., Costanzo M.R., Bellomo R. et al. Fluid overload. Diagnosis and management. Contrib Nephrology 2011; 164.

  16. Bellomo R., Ronco C., Kellum J. et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.

  17. Mehta R., Kellum J., Shah S. et al. Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.

  18. Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline. J. Card Fail. 2010; 16(6): 475-539.

  19. Felker G.M., Lee K.L., Bull D.A. et al. Diuretic Strategies in Patients with Acute Decompensated Heart Failure. N. Engl. J. Med. 2011; 364:797-805.

  20. Fonarow G.C. Comparative effectiveness of diuretic regimens. N. Engl. J. Med. 2011; 364(9): 797-805.

  21. Costanzo M.R., Guglin M.E., Saltzberg M.T. et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J. Am. Coll. Cardiol. 2007; 49(6): 675-683.

  22. Giamouzis G., Butler J., Starling R.C. et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J. Card. Fail. 2010; 16(12): 922-930.

  23. Konstam M.A., Gheorghiade M., Burnett J.C. Jr. et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007; 297(12): 1319-1331.

  24. Voors A.A., Dittrich H.C., Massie B.M. et al. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function. J. Am. Coll. Cardiol. 2011; 57(19): 1899-1907.

  25. O'Connor C.M., Starling R.C., Hernandez A.F. et al. Effect ofnesiritide in patients with acute decompensated heart failure. N. Engl. J. Med. 2011; 365(1): 32-43.

  26. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39(1): 1-266.

  27. Jose P., Skali H., Anavekar N. et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J. Am. Soc. Nephrol. 2006; 17 (10): 2886-2891.

  28. de Silva R., Nikitin N. P., Witte K. K.A. et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur. Heart J. 2006; 27(5): 569-581.


Об авторах / Для корреспонденции


Кобалава Ж.Д. - профессор кафедры пропедевтики внутренних болезней РУДН, д.м.н.;
Виллевальде С.В. – профессор кафедры пропедевтики внутренних болезней РУДН, д.м.н.;
Клименко А.С. – ассистент кафедры пропедевтики внутренних болезней РУДН.
E-mail: zavyalova_a@mail.ru;
Ефремовцева М.А. – доцент кафедры пропедевтики внутренних болезней РУДН, к.м.н.;
Мильто А.С. – доцент кафедры пропедевтики внутренних болезней РУДН, д.м.н.


Похожие статьи


Бионика Медиа